KemPharm
KMPH
#8874
Rank
A$0.30 B
Marketcap
A$8.78
Share price
-0.34%
Change (1 day)
3.88%
Change (1 year)

EPS for KemPharm (KMPH)

EPS in 2022 (TTM): A-$1.45

According to KemPharm's latest financial reports the company's current EPS (TTM) is A-$1.50. In 2016 the company made an earnings per share (EPS) of A-$29.25 an increase over its 2015 EPS that were of A-$102.86.

EPS history for KemPharm from 2015 to 2022

Annual EPS

Year EPS Change
2022 (TTM)A-$1.45
2016A-$29.25-71.57%
2015A-$102.86

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Theravance Biopharma
TBPH
A$1.60-207.07% Cayman Islands
Jazz Pharmaceuticals
JAZZ
A$5.48-466.67%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
ANI Pharmaceuticals
ANIP
A$7.83-623.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Agile Therapeutics
AGRX
A-$5.85 290.91%๐Ÿ‡บ๐Ÿ‡ธ USA